Search research articles
Contact Us
Filters
Showing results (261-270 of 307) with videos related to
Page
of 31
Sort By:
The Cancer Journal From Scientific American
|
April 13, 1999
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy
G Gasparini, M Toi, R Miceli, et al.
Oncology
|
October 17, 2002
Doxorubicin-docetaxel sequential schedule: results of front-line treatment in advanced breast cancer
S Palmeri, V Leonardi, M Tamburo De Bella, et al.
International Journal of Oncology
|
April 30, 2011
Phase I study of carboplatin, cisplatin, and cyclophosphamide without and with lenograstim for the treatment of ovarian cancer
S Pignata, R Lauria, F Perrone, et al.
Oncology
|
November 29, 2008
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial
S Pignata, G Scambia, A Savarese, et al.
Cancer Research
|
June 11, 1999
Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines
P Giacomini, E Giorda, R Fraioli, et al.
Melanoma Research
|
December 22, 1999
Multi-institutional phase II randomized trial of integrated therapy with cisplatin, dacarbazine, vindesine, subcutaneous interleukin-2, interferon alpha2a and tamoxifen in metastatic melanoma. BREMIM (Biological Response Modifiers in Melanoma)
M R Sertoli, P Queirolo, E Bajetta, et al.
Alimentary Pharmacology & Therapeutics
|
March 25, 2014
Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients
G D'Amico, L Pasta, A Morabito, et al.
Oncology Reports
|
May 25, 2011
Cardiovascular monitoring of drug-resistant lymphoma patients treated with epoch chemotherapy plus high-dose verapamil in continuous-infusion
P Tagliaferri, P Correale, M Mottola, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
May 10, 2005
Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003
E Faglia, L Dalla Paola, G Clerici, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
October 23, 2010
Vandetanib: An overview of its clinical development in NSCLC and other tumors
A Morabito, M C Piccirillo, R Costanzo, et al.
Page
of 31
Search research articles
Search
Showing results (261-270 of 307) with videos related to
Sort By:
Page
of 31
The Cancer Journal From Scientific American
|
April 13, 1999
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy
G Gasparini, M Toi, R Miceli, et al.
Oncology
|
October 17, 2002
Doxorubicin-docetaxel sequential schedule: results of front-line treatment in advanced breast cancer
S Palmeri, V Leonardi, M Tamburo De Bella, et al.
International Journal of Oncology
|
April 30, 2011
Phase I study of carboplatin, cisplatin, and cyclophosphamide without and with lenograstim for the treatment of ovarian cancer
S Pignata, R Lauria, F Perrone, et al.
Oncology
|
November 29, 2008
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial
S Pignata, G Scambia, A Savarese, et al.
Cancer Research
|
June 11, 1999
Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines
P Giacomini, E Giorda, R Fraioli, et al.
Melanoma Research
|
December 22, 1999
Multi-institutional phase II randomized trial of integrated therapy with cisplatin, dacarbazine, vindesine, subcutaneous interleukin-2, interferon alpha2a and tamoxifen in metastatic melanoma. BREMIM (Biological Response Modifiers in Melanoma)
M R Sertoli, P Queirolo, E Bajetta, et al.
Alimentary Pharmacology & Therapeutics
|
March 25, 2014
Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients
G D'Amico, L Pasta, A Morabito, et al.
Oncology Reports
|
May 25, 2011
Cardiovascular monitoring of drug-resistant lymphoma patients treated with epoch chemotherapy plus high-dose verapamil in continuous-infusion
P Tagliaferri, P Correale, M Mottola, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
May 10, 2005
Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003
E Faglia, L Dalla Paola, G Clerici, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
October 23, 2010
Vandetanib: An overview of its clinical development in NSCLC and other tumors
A Morabito, M C Piccirillo, R Costanzo, et al.
Page
of 31